Labarrere CA - Search Results

1

Vascular antithrombin and clinical outcome in heart transplant patients.

Labarrere CA, Torry RJ, Nelson DR, Miller SJ, Pitts DE, Kirlin PC, Halbrook HG. Labarrere CA, et al. Am J Cardiol. 2001 Feb 15;87(4):425-31. doi: 10.1016/s0002-9149(00)01395-3. Am J Cardiol. 2001. PMID: 11179526

2

C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study.

Labarrere CA, Lee JB, Nelson DR, Al-Hassani M, Miller SJ, Pitts DE. Labarrere CA, et al. Lancet. 2002 Nov 9;360(9344):1462-7. doi: 10.1016/S0140-6736(02)11473-5. Lancet. 2002. PMID: 12433514

3

Value of the first post-transplant biopsy for predicting long-term cardiac allograft vasculopathy (CAV) and graft failure in heart transplant patients.

Labarrere CA, Woods JR, Hardin JW, Campana GL, Ortiz MA, Jaeger BR, Baldridge LA, Pitts DE, Kirlin PC. Labarrere CA, et al. PLoS One. 2012;7(4):e36100. doi: 10.1371/journal.pone.0036100. Epub 2012 Apr 25. PLoS One. 2012. PMID: 22558345 Free PMC article. Clinical Trial.

4

Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients.

Labarrere CA, Pitts D, Nelson DR, Faulk WP. Labarrere CA, et al. N Engl J Med. 1995 Oct 26;333(17):1111-6. doi: 10.1056/NEJM199510263331704. N Engl J Med. 1995. PMID: 7565949 Free article.

5

Coronary artery disease in cardiac allografts: association with arterial antithrombin.

Faulk WP, Labarrere CA, Nelson DR, Pitts D. Faulk WP, et al. Among authors: labarrere ca. Transplant Proc. 1995 Jun;27(3):1944-6. Transplant Proc. 1995. PMID: 7792845 No abstract available.

6

Tissue plasminogen activator, plasminogen activator inhibitor-1, and fibrin as indexes of clinical course in cardiac allograft recipients. An immunocytochemical study.

Labarrere CA, Pitts D, Halbrook H, Faulk WP. Labarrere CA, et al. Circulation. 1994 Apr;89(4):1599-608. doi: 10.1161/01.cir.89.4.1599. Circulation. 1994. PMID: 8149527

7

Laboratory-clinical correlates of time-associated lesions in the vascular immunopathology of human cardiac allografts.

Faulk WP, Labarrere CA, Pitts D, Halbrook H. Faulk WP, et al. Among authors: labarrere ca. J Heart Lung Transplant. 1993 Mar-Apr;12(2):S125-34. J Heart Lung Transplant. 1993. PMID: 8476882

8

Vascular lesions in biopsy specimens devoid of cellular infiltrates: qualitative and quantitative immunocytochemical studies of human cardiac allografts.

Faulk WP, Labarrere CA, Pitts D, Halbrook H. Faulk WP, et al. Among authors: labarrere ca. J Heart Lung Transplant. 1993 Mar-Apr;12(2):219-29. J Heart Lung Transplant. 1993. PMID: 8476894

9

Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients.

Labarrere CA, Nelson DR, Faulk WP. Labarrere CA, et al. Am J Med. 1998 Sep;105(3):207-13. doi: 10.1016/s0002-9343(98)00246-0. Am J Med. 1998. PMID: 9753023

10

Tubular antithrombin at transplantation determines subsequent renal allograft function.

Torry RJ, Labarrere CA, Nelson D, Carter C, Haag B, Faulk WP. Torry RJ, et al. Among authors: labarrere ca. Transplantation. 1998 Sep 27;66(6):797-9. doi: 10.1097/00007890-199809270-00016. Transplantation. 1998. PMID: 9771845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters